NCT00622037View on ClinicalTrials.gov

Bilateral, Masked Comparison of PEG-400 Based Artificial Tear and Systane for the Treatment of Dry Eye Signs, Symptoms and Visual Quality

PHASE4CompletedINTERVENTIONAL
Enrollment

70

Participants

Timeline

Start Date

February 29, 2008

Primary Completion Date

May 31, 2008

Study Completion Date

May 31, 2008

Conditions
Dry Eye
Interventions
DRUG

PEG-400 based artificial tear

Instill one drop in the randomized eye four times daily. Can be used more frequently if needed

DRUG

Systane

Instill one drop in the randomized eye four times daily. Can be used more frequently if needed

Trial Locations (1)

33426

Florida Microsurgical Eye Institute, Boynton Beach

Sponsors

Lead Sponsor

Bp Consulting, Inc
All Listed Sponsors
lead

Bp Consulting, Inc

NETWORK

NCT00622037 - Bilateral, Masked Comparison of PEG-400 Based Artificial Tear and Systane for the Treatment of Dry Eye Signs, Symptoms and Visual Quality | Biotech Hunter | Biotech Hunter